Correction to “Orally Active Opioid µ/d Dual Agonist MGM-16, a Derivative of the Indole Alkaloid Mitragynine, Exhibits Potent Antiallodynic Effect on Neuropathic Pain in Mice”

In the above article [Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M, Tashima K, Devi LA, Suzuki T, Takayama H, and Horie S (2014) J Pharmacol Exp Ther 348(3):383–392; DOI:10.1124/jpet.113.208108], the following funding information was omitted:

This work was funded by the National Institutes of Health [Grants DA 008863 and NS 026880].

The authors regret this error and any inconvenience it may have caused.